These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 10445388

  • 1. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
    Daniel WA, Syrek M, Haduch A, Wójcikowski J.
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA, Syrek M, Haduch A, Wójcikowski J.
    Pol J Pharmacol; 1998 Jul; 50(6):431-42. PubMed ID: 10385926
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE, Ahern D, Scatina J, Kao J.
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors.
    Baumann P.
    Clin Pharmacokinet; 1996 Dec; 31(6):444-69. PubMed ID: 8968657
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
    Daniel WA, Syrek M, Mach A, Wójcikowski J, Boksa J.
    Pol J Pharmacol; 1997 Dec; 49(6):439-52. PubMed ID: 9566048
    [Abstract] [Full Text] [Related]

  • 9. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
    Daniel WA, Haduch A, Wójcikowski J.
    J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
    [Abstract] [Full Text] [Related]

  • 10. The effect of tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs) and newer antidepressant drugs on the activity and level of rat CYP3A.
    Haduch A, Wójcikowski J, Daniel WA.
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):178-86. PubMed ID: 16246530
    [Abstract] [Full Text] [Related]

  • 11. Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.
    Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.
    Clin Pharmacokinet; 1997 Dec; 33(6):454-71. PubMed ID: 9435993
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.
    Daniel WA, Wójcikowski J.
    Toxicol Appl Pharmacol; 1999 Jul 15; 158(2):115-24. PubMed ID: 10406926
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes.
    Hemeryck A, De Vriendt C, Belpaire FM.
    Eur J Clin Pharmacol; 1999 Feb 15; 54(12):947-51. PubMed ID: 10192756
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycin.
    Desta Z, Soukhova N, Flockhart DA.
    J Clin Psychopharmacol; 2002 Apr 15; 22(2):162-8. PubMed ID: 11910261
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.